Longeveron Inc.

LGVN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $27.4M

Liabilities Breakdown FY2022

Total Liabilities: $6.9M